A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: Biochemical and pharmacological considerations

British Journal of Pharmacology

Volumn 144, Issue 6, 2005, Pages 849-859

  Crane, Michael S ^a   Rossi, Adriano G ^b   Megson, Ian L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Caeruloplasmin; cGMP independent; Cyclic GMP; Nitric oxide; Peroxynitrite; Platelet activation; S nitrosothiols; Soluble guanylate cyclase; Superoxide dismutase

Indexed keywords

CALCIUM; CERULOPLASMIN; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIC GMP; DIETHYLAMINE DIAZENIUMDIOLATE; FURA 2; GUANYLATE CYCLASE INHIBITOR; LINSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; PEROXYNITRITE; S NITROSO N VALERYLPENICILLAMINE; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRODE; HUMAN; HUMAN CELL; NORMAL HUMAN; PLASMA FACTOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ADULT; BLOOD PLATELETS; CALCIUM; CYCLIC GMP; CYTOSOL; HUMANS; MICROELECTRODES; NITRIC OXIDE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 17144428125     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706110     Document Type: Article

References (65)

1. AHERN, G.P., KLYACHKO, V.A. & JACKSON, M.B. (2002). cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci., 25, 510-517.
2. BELLAMY, T.C., WOOD, J., GOODWIN, D.A. & GARTHWAITE, J. (2000). Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl. Acad. Sci. U.S.A., 97, 2928-2933.
3. BLOCKMANS, D., DECKMYN, H. & VERMYLEN, J. (1995). Platelet activation. Blood Rev., 9, 143-156.
4. BROWN, A.S., MORO, M.A., MASSE, J.M., CRAMER, E.M., RADOMSKI, M. & DARLEY-USMAR, V. (1998). Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite. Cardiovasc. Res., 40, 380-388.
5. BUSSE, R., LUCKHOFF, A. & BASSENGE, E. (1987). Endothelium-derived relaxant factor inhibits platelet activation. Naunyn Schmiedebergs Arch. Pharmacol, 336, 566-571.
6. CAVALLINI, L., COASSIN, M., BOREAN, A. & ALEXANDRE, A. (1996). Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J. Biol. Chem., 271, 5545-5551.
7. CRANE, M.S., OLLOSSON, R., MOORE, K.P., ROSSI, A.G. & MEGSON, I.L. (2002). Novel role for low molecular weight plasma thiols in nitric oxide-mediated control of platelet function. J. Biol. Chem., 277, 46858-46863.
8. DAVIES, K.M., WINK, D.A., SAAVEDRA, J.E. & KEEPER, L.K. (2001). Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J. Am. Chem. Soc., 123, 5473-5481.
9. DICKS, A.P. & WILLIAMS, D.L. (1996). Generation of nitric oxide from S-nitrosothiols using protein-bound Cu2+ sources. Chem. Biol., 3, 655-659.
10. ESPEY, M.G., MIRANDA, K.M., THOMAS, D.D., XAVIER, S.. CITRIN, D., VITEK, M.P. & WINK, D.A. (2002). A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species. Ann. NY Acad. Sci., 962, 195-206.
11. ESTEVE, M.J., FARRE, R., FRIGOLA, A. & GARCIA-CANTABELLA, J.M. (1997). Determination of ascorbic and dehydroascorbic acids in blood plasma and serum by liquid chromatography. J. Chromatogr B Biomed. Sci. Appl., 688, 345-349.
12. FEELISCH, M., OSTROWSKI, J. & NOACK, E. (1989). On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol., 14 (Suppl 11), S13-S22.
13. GERRARD, J.M., WHITE, J.G. & PETERSON, D.A. (1978). The platelet dense tubular system: its relationship to prostaglandin synthesis and calcium flux. Thromb. Haemost., 40, 224-231.
14. GORDGE, M.P., HOTHERSALL, J.S. & NORONHA-DUTRA, A.A. (1998). Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Br. J. Pharmacol., 124, 141-148.
15. GOW, A.J., BUERK, D.G. & ISCHIROPOULOS, H. (1997). A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J. Biol. Chem., 272, 2841-2845.
16. GOW, A.J., LUCHSINGER, B.P., PAWLOSKI, J.R., SINGEL, D.J. & STAMLER, J.S. (1999). The oxyhemoglobin reaction of nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 96, 9027-9032.
17. HOMER, K.L., FIORE, S.A. & WANSTALL, J.C. (1999). Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation. J. Pharm. Pharmacol., 51, 135-139.
18. HOMER, K.L. & WANSTALL, J.C. (2002). Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate. Br. J. Pharmacol., 137, 1071-1081.
19. HORIGUCHI, M., KIMURA, M., LYTTON, J., SKURNICK, J., NASH, F., AWAD, G., POCH, E. & AVIV, A. (1998). Ca2+ in the dense tubules: a model of platelet Ca2+ load. Hypertension, 31, 595-602.
20. HUIE, R.E. & PADMAJA, S. (1993). The reaction of no with superoxide. Free Radical Res. Commun., 18, 195-199.
21. IGNARRO, L.J., LIPPTON, H., EDWARDS, J.C., BARICOS, W.H., HYMAN, A.L., KADOWITZ, P.J. & GRUETTER, C.A. (1981). Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther., 218, 739-749.
22. INOUE, K., AKAIKE, T., MIYAMOTO, Y., OKAMOTO, T., SAWA, T., OTAGIRI, M., SUZUKI, S., YOSHIMURA, T. & MAEDA, H. (1999). Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J. Biol Chem., 274, 27069-27075.
23. JOURD'HEUIL, D., JOURD'HEUIL, F.L., KUTCHUKIAN, P.S., MUSAH, R.A., WINK, D.A. & GRISHAM, M.B. (2001). Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo. J. Biol. Chem., 276, 28799-28805.
24. KAWAHARA, Y., YAMANISHI, J. & FUKUZAKI, H. (1984). Inhibitory action of guanosine 3′,5′-monophosphate on thrombin-induced calcium mobilization in human platelets. Thromb. Res., 33, 203-209.
25. KEYNES, R.G., GRIFFITHS, C. & GARTHWAITE, J. (2003). Superoxide-dependent consumption of nitric oxide in biological media may confound in vitro experiments. Biochem. J., 369, 399-406.
26. KHARITONOV, V.G., SUNDQUIST, A.R. & SHARMA, V.S. (1995). Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J. Biol. Chem., 270, 28158-28164.
27. LENTENER, C. (1984). Geigy Scientific Tables. Basel, Switzerland: Ciba Geigy Limited.
28. LIJANA, R.C. & WILLIAMS, M.C. (1979). Tetramethylbenzidine - a substitute for benzidine in hemoglobin analysis. J. Lab. Clin. Med., 94, 266-276.
29. LI, Z., XI, X., GU, M., FEIL, R., YE, R.D., EIGENTHALER, M., HOFMANN, F. & DU, X. (2003). A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell, 112, 77-86.
30. MANSOOR, M.A., SVARDAL, A.M. & UELAND, P.M. (1992). Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal. Biochem., 200, 218-229.
31. MATSUOKA, I., NAKAHATA, N. & NAKANISHI, H. (1989). Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2 +-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets. Biochem. Pharmacol., 38, 1841-1847.
32. MAYER, B., PFEIFFER, S., SCHRAMMEL, A., KOESLING, D., SCHMIDT, K. & BRUNNER, F. (1998). A new pathway of nitric oxide/cyclic GMP signaling involving 5-nitrosoglutathione. J. Biol. Chem., 273, 3264-3270.
33. MCDONALD, L.J. & MURAD, F. (1995). Nitric oxide and cGMP signaling. Adv. Pharmacol., 34, 263-275.
34. MEGSON, I.L., MORTON, S., GREIG, I.R., MAZZEI, F.A., FIELD, R.A., BUTLER, A.R., CARON, G., GASCO, A., FRUTTERO, R. & WEBB, D.J. (1999). N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries. Br. J. Pharmacol., 126, 639-648.
35. MILLER, M.R., OKUBO, K., ROSEBERRY, M.J., WEBB, D.J. & MEGSON, I.L. (2004). Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteries. J. Cardiovasc. Pharmacol., 43, 440-451.
36. MILLER, M.R., ROSEBERRY, M.J., MAZZEI, F.A., BUTLER, A.R., WEBB, D.J. & MEGSON, I.L. (2000). Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries. Eur. J. Pharmacol., 408, 335-343.
37. MORO, M.A., DARLEY-USMAR, V.M., GOODWIN, D.A., READ, N.G., ZAMORA-PINO, R., FEELISCH, M., RADOMSKI, M.W. & MONCADA, S. (1994). Paradoxical fate and biological action of peroxynitrite on human platelets. Proc. Natl. Acad. Sci. U.S.A., 91, 6702-6706.
38. MORO, M.A., RUSSEL, R.J., CELLEK, S., LIZASOAIN, I., SU, Y., DARLEY-USMAR, V.M., RADOMSKI, M.W. & MONCADA, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A., 93, 1480-1485.
39. MURER, E.H. (1985). The role of platelet calcium. Semin. Hematol., 22, 313-323.
40. NAKASHIMA, S., TOHMATSU, T., HATTORI, H., OKANO, Y. & NOZAWA, Y. (1986). Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets. Biochem. Biophys. Res. Commun., 135, 1099-1104.
41. NOACK, E. & FEELISCH, M. (1991). Molecular mechanisms of nitrovasodilator bioactivation. Basic Res. Cardiol., 86 (Suppl 2), 37-50.
42. PALMER, R.M., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666.
43. PALMER, R.M., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-526.
44. PAWLOSKI, J.R., SWAMINATHAN, R.V. & STAMLER, J.S. (1998). Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation. Circulation, 97, 263-267.
45. PIGAZZI, A., HEYDRICK, S., FOLLI, F., BENOIT, S., MICHELSON, A. & LOSCALZO, J. (1999). Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. J. Biol. Chem., 274, 14368-14375.
46. PRAKASAM, A., SETHUPATHY, S. & LALITHA, S. (2001). Plasma and RBCs antioxidant status in occupational male pesticide sprayers. Clin. Chim. Acta., 310, 107-112.
47. RADOMSKI, M.W., PALMER. R.M. & MONCADA, S. (1987a). The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol., 92, 639-646.
48. RADOMSKI, M.W., PALMER, R.M. & MONCADA, S. (1987b). Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet, 2, 1057-1058.
49. RADOMSKI, M.W., PALMER, R.M. & MONCADA, S. (1987c). The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun., 148, 1482-1489.
50. RADOMSKI, M.W., PALMER, R.M. & MONCADA, S. (1990). An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. U.S.A., 87, 5193-5197.
51. RAVIN, H.A. (1961). An improved colorimetric enzymatic assay of ceruloplasmin. J. Lab. Clin. Med., 58, 161-168.
52. RINK, T.J. (1988). Cytosolic calcium in platelet activation. Experientia, 44, 97-100.
53. SCHARFSTEIN, J.S., KEANEY JR, J.F., SLIVKA, A., WELCH, G.N., VITA, J.A., STAMLER, J.S. & LOSCALZO, J. (1994). In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J. Clin. Invest., 94, 1432-1439.
54. SIMON, D.I., STAMLER, J.S., JARAKI, O., KEANEY, J.F., OSBORNE, J.A., FRANCIS, S.A., SINGEL, D.J. & LOSCALZO, J. (1993). Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb., 13, 791-799.
55. SINGH, R.J., HOGG, N., JOSEPH, J. & KALYANARAMAN, B. (1996). Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem., 271, 18596-18603.
56. SOGO, N., MAGID, K.S., SHAW, C.A., WEBB, D.J. & MEGSON, I.L. (2000). Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Biochem. Biophys. Res. Commun., 279, 412-419.
57. STAMLER, J.S., JARAKI, O., OSBORNE, J., SIMON, D.I., KEANEY, J., VITA, J., SINGEL, D., VALERI, C.R. & LOSCALZO, J. (1992). Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. U.S.A., 89, 7674-7677.
58. STANDEFER, J.C. & VANDERJAGT, D. (1977). Use of tetramethyl-benzidine in plasma hemoglobin assay. Clin. Chem., 23, 749-751.
59. TAYLOR, E.L., ROSSI, A.G., SHAW, C.A., DAL RIO, F.P., HASLETT, C. & MEGSON, I.L. (2004). GEA 3162 decomposes to co-generate nitric oxide and superoxide and induces apoptosis in human neutrophils via a peroxynitrite- dependent mechanism. Br. J. Pharmacol., 143, 179-185.
60. THYAGARAJAN, B., MALLI, R., SCHMIDT, K., GRAIER, W.F. & GROSCHNER, K. (2002). Nitric oxide inhibits capacitative Ca2 + entry by suppression of mitochondrial Ca2+ handling. Br. J. Pharmacol., 137, 821-830.
61. TREPAKOVA, E.S., COHEN, R.A. & BOLOTINA, V.M. (1999). Nitric oxide inhibits capacitative cation influx in human platelets by promoting sarcoplasmic/endoplasmic reticulum Ca2 + -ATPase-dependent refilling of Ca2+ stores. Circ. Res., 84, 201-209.
62. TSIKAS, D., IKIC, M., TEWES, K.S., RAIDA, M. & FROLICH, J.C. (1999). Inhibition of platelet aggregation by 5-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets. FEBS Lett., 442, 162-166.
63. WANG, G.R., ZHU, Y., HALUSHKA, P.V., LINCOLN, T.M. & MENDELSOHN, M.E. (1998). Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A., 95, 4888-4893.
64. WHITE, T.A., WALSETH, T.F. & KANNAN, M.S. (2002). Nitric oxide inhibits ADP-ribosyl cyclase through a cGMP-independent pathway in airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol., 283, L1065-L1071.
65. ZHAO, Y., BRANDISH, P.E., DIVALENTIN, M., SCHELVIS, J.P., BABCOCK, G.T. & MARLETTA, M.A. (2000). Inhibition of soluble guanylate cyclase by ODQ. Biochemistry, 39, 10848-10854.